14,166 Shares in Sanofi $SNY Acquired by Storgate LLC

Storgate LLC acquired a new position in shares of Sanofi (NASDAQ:SNY) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 14,166 shares of the company’s stock, valued at approximately $686,000.

Other large investors have also recently modified their holdings of the company. Flagship Harbor Advisors LLC bought a new position in shares of Sanofi during the 4th quarter worth approximately $25,000. Measured Wealth Private Client Group LLC acquired a new position in Sanofi during the 3rd quarter valued at approximately $29,000. Palisade Asset Management LLC acquired a new position in Sanofi during the 3rd quarter valued at approximately $30,000. Annis Gardner Whiting Capital Advisors LLC increased its stake in Sanofi by 544.4% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 696 shares of the company’s stock valued at $34,000 after purchasing an additional 588 shares in the last quarter. Finally, Larson Financial Group LLC increased its stake in Sanofi by 48.9% during the 4th quarter. Larson Financial Group LLC now owns 810 shares of the company’s stock valued at $39,000 after purchasing an additional 266 shares in the last quarter. Institutional investors own 14.03% of the company’s stock.

Wall Street Analyst Weigh In

SNY has been the topic of a number of recent analyst reports. Weiss Ratings upgraded shares of Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 13th. Citigroup restated a “neutral” rating on shares of Sanofi in a research note on Monday, April 13th. BNP Paribas Exane lowered shares of Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 price target on the stock. in a research note on Monday, April 20th. Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a research note on Thursday, March 19th. Finally, Morgan Stanley set a $52.00 price target on shares of Sanofi in a research note on Friday, May 1st. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $51.00.

Sanofi Stock Up 0.3%

NASDAQ:SNY opened at $44.25 on Friday. The firm has a market capitalization of $107.28 billion, a P/E ratio of 12.36, a PEG ratio of 1.09 and a beta of 0.34. Sanofi has a 1-year low of $42.28 and a 1-year high of $52.68. The company’s fifty day moving average price is $45.14 and its 200-day moving average price is $46.55. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.01 and a quick ratio of 0.22.

Sanofi Increases Dividend

The firm also recently disclosed an annual dividend, which was paid on Wednesday, June 3rd. Stockholders of record on Monday, May 4th were paid a $2.4225 dividend. The ex-dividend date was Monday, May 4th. This is an increase from Sanofi’s previous annual dividend of $2.04. This represents a dividend yield of 559.0%. Sanofi’s dividend payout ratio (DPR) is currently 49.16%.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.